Results 121 to 130 of about 22,516 (228)

Comparison of Disease Progression From Prostate Cancer Diagnosis to Metastatic or Nonmetastatic Castrate‐Resistant Prostate Cancer (CRPC) Patients: CaPA Study

Background Prostate cancer (PC) patients resistant to castration have decreased survival. Analysis of patient characteristics and disease management can contribute to new strategies to prevent or delay progression to castrate‐resistant prostate cancer ...
Pedro Costa, Luís Campos Pinheiro, Ricardo Borges, Inês Sequeira, João Vasco Barreira, Paulo Azinhais, António Canelas, Hugo Coelho, Ferdinando Pereira, José Carvalho, Fernando Vila, Luís Abranches Monteiro, José Palma dos Reis, Frederico Reis, Carlos Rabaça, Rui Dinis, Ana Cristina Fialho, António Patrício, Francisco Botelho, Sílvia Dias   +19 more
core   +1 more source

Neutropenia in Patients With Castration-Resistant Prostate Cancer Treated Using Cabazitaxel and Prophylactic Administration of Pegfilgrastim. [PDF]

Adv Urol
Oshinomi K, Kikuchi S, Kurokawa M, Mugita T, Inoue T, Yamagishi M, Nakagami Y, Nagata M, Sasaki H, Fuji K, Morita M, Fukagai T.   +11 more
europepmc   +1 more source

Patient-derived prostate cancer organoids: model development, therapeutic applications, and challenges for precision oncology. [PDF]

Front Oncol
Zhu J, Wang S, Du F, Shao S.
europepmc   +1 more source

Magnocurarine inhibits migration and invasion by suppressing mesenchymal marker expression and MAPK signaling in castration-resistant prostate cancer cells. [PDF]

Front Pharmacol
Semmarath W, Arjsri P, Srisawad K, Thippraphan P, Intanil I, Umsumarng S, Dejkriengkraikul P.   +6 more
europepmc   +1 more source

The role of molecular profiling for castration-resistant prostate cancer treatment and therapy development. [PDF]

Front Cell Dev Biol
Mann TJ, Becker TM, Roberts TL, de Souza P, Lock JG.   +4 more
europepmc   +1 more source

Mitochondrial convergence of ferroptosis and cuproptosis in castration-resistant prostate cancer: From metabolic vulnerabilities to therapeutic targeting. [PDF]

BBA Adv
Wang CL, Lv JT, Liu SJ, Zhang YY, Wang SL, Song SQ.   +5 more
europepmc   +1 more source

Developing a Fluorescence-Based High-Throughput Screening Method for Natural Product Fractions to Identify Inhibitors of AR-V7 for Castration-Resistant Prostate Cancer. [PDF]

Pharmaceutics
Tyagi N, Rathi M, Ensel S, Thornburg CC, Grkovic T, O'Keefe BR, Sacchettini JC, Damodaran C.   +7 more
europepmc   +1 more source

Castratieresistent prostaatcarcinoom (CRPC)

Tijdschrift voor Urologie, 2012
openaire   +1 more source

Engineered human adipose-derived stem cells delivering carboxylesterase and TRAIL for castration-resistant prostate cancer: Translational synthesis. [PDF]

Investig Clin Urol
Kim JH, Lee SH, Song YS.
europepmc   +1 more source

New nonsteroidal compound for treating CRPC [PDF]

Nature Reviews Urology, 2018
openaire   +2 more sources